ArticleScience advances2026

Dual-receptor targeting of type I dendritic cells with DNA-scaffolded nanoparticles enhances STING-licensed antitumor immunity.

Deblin Jana et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.